Cerebral mucormycosis: intranasal route to deliver amphotericin B for effective management?

Ruqaiyyah Siddiqui; Mohamed Yehia Abouleish; Mustafa Khamis; Taleb Ibrahim; Naveed Ahmed Khan

doi:10.1080/03007995.2021.2000779

Cerebral mucormycosis: intranasal route to deliver amphotericin B for effective management?

Ruqaiyyah Siddiqui, Mohamed Yehia Abouleish, Mustafa Khamis, Taleb Ibrahim, Naveed Ahmed Khan

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Abstract

As cerebral mucormycosis is devastating in nature, here we discuss possible use of the intranasal route, in comparison to or in addition to intravenous administration, as a therapeutic approach to manage cases of mucormycosis with central nervous system involvement.

Original language	English
Pages (from-to)	299-301
Number of pages	3
Journal	Current Medical Research and Opinion
Volume	38
Issue number	2
Early online date	12 Nov 2021
DOIs	https://doi.org/10.1080/03007995.2021.2000779
Publication status	Published - 1 Feb 2022

Access to Document

10.1080/03007995.2021.2000779

Cite this

@article{3d77ef5ee1484bc1a8d9485aecb8b191,

title = "Cerebral mucormycosis: intranasal route to deliver amphotericin B for effective management?",

abstract = "As cerebral mucormycosis is devastating in nature, here we discuss possible use of the intranasal route, in comparison to or in addition to intravenous administration, as a therapeutic approach to manage cases of mucormycosis with central nervous system involvement.",

author = "Ruqaiyyah Siddiqui and Abouleish, \{Mohamed Yehia\} and Mustafa Khamis and Taleb Ibrahim and Khan, \{Naveed Ahmed\}",

year = "2022",

month = feb,

day = "1",

doi = "10.1080/03007995.2021.2000779",

language = "English",

volume = "38",

pages = "299--301",

journal = "Current Medical Research and Opinion",

issn = "0300-7995",